Recursion Pharmaceuticals, Inc. (RXRX)
3.11
+0.15
(+5.07%)
USD |
NASDAQ |
May 21, 16:00
3.11
0.00 (0.00%)
After-Hours: 19:59
Recursion Pharmaceuticals Research and Development Expense (TTM) : 382.53M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 351.67M |
| Tango Therapeutics, Inc. | 127.14M |
| KalVista Pharmaceuticals, Inc. | 48.42M |
| Ionis Pharmaceuticals, Inc. | 923.53M |
| Ironwood Pharmaceuticals, Inc. | 87.80M |